Cargando…

Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

Detalles Bibliográficos
Autores principales: Chui, M. Herman, Kjaer, Susanne K., Frederiksen, Kirsten, Hannibal, Charlotte G., Wang, Tian-Li, Vang, Russell, Shih, Ie-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238241/
https://www.ncbi.nlm.nih.gov/pubmed/34194631
http://dx.doi.org/10.18632/oncotarget.28001
_version_ 1783714862357020672
author Chui, M. Herman
Kjaer, Susanne K.
Frederiksen, Kirsten
Hannibal, Charlotte G.
Wang, Tian-Li
Vang, Russell
Shih, Ie-Ming
author_facet Chui, M. Herman
Kjaer, Susanne K.
Frederiksen, Kirsten
Hannibal, Charlotte G.
Wang, Tian-Li
Vang, Russell
Shih, Ie-Ming
author_sort Chui, M. Herman
collection PubMed
description
format Online
Article
Text
id pubmed-8238241
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-82382412021-06-29 Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma Chui, M. Herman Kjaer, Susanne K. Frederiksen, Kirsten Hannibal, Charlotte G. Wang, Tian-Li Vang, Russell Shih, Ie-Ming Oncotarget Correction Impact Journals LLC 2021-06-22 /pmc/articles/PMC8238241/ /pubmed/34194631 http://dx.doi.org/10.18632/oncotarget.28001 Text en Copyright: © 2021 Chui et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Chui, M. Herman
Kjaer, Susanne K.
Frederiksen, Kirsten
Hannibal, Charlotte G.
Wang, Tian-Li
Vang, Russell
Shih, Ie-Ming
Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
title Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
title_full Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
title_fullStr Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
title_full_unstemmed Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
title_short Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
title_sort correction: braf(v600e)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238241/
https://www.ncbi.nlm.nih.gov/pubmed/34194631
http://dx.doi.org/10.18632/oncotarget.28001
work_keys_str_mv AT chuimherman correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma
AT kjaersusannek correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma
AT frederiksenkirsten correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma
AT hannibalcharlotteg correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma
AT wangtianli correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma
AT vangrussell correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma
AT shihieming correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma